389 related articles for article (PubMed ID: 38690275)
1. Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment.
Lv D; Fei Y; Chen H; Wang J; Han W; Cui B; Feng Y; Zhang P; Chen J
Front Immunol; 2024; 15():1340702. PubMed ID: 38690275
[TBL] [Abstract][Full Text] [Related]
2. Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy.
Mai Z; Lin Y; Lin P; Zhao X; Cui L
Cell Death Dis; 2024 May; 15(5):307. PubMed ID: 38693104
[TBL] [Abstract][Full Text] [Related]
3. Role of cell surface proteoglycans in cancer immunotherapy.
Espinoza-Sánchez NA; Götte M
Semin Cancer Biol; 2020 May; 62():48-67. PubMed ID: 31336150
[TBL] [Abstract][Full Text] [Related]
4. Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers.
Mushtaq MU; Papadas A; Pagenkopf A; Flietner E; Morrow Z; Chaudhary SG; Asimakopoulos F
J Immunother Cancer; 2018 Jul; 6(1):65. PubMed ID: 29970158
[TBL] [Abstract][Full Text] [Related]
5. Mechanoimmunology in the solid tumor microenvironment.
Golo M; Newman PLH; Kempe D; Biro M
Biochem Soc Trans; 2024 Jun; 52(3):1489-1502. PubMed ID: 38856041
[TBL] [Abstract][Full Text] [Related]
6. Obstacles to T cell migration in the tumor microenvironment.
Nicolas-Boluda A; Donnadieu E
Comp Immunol Microbiol Infect Dis; 2019 Apr; 63():22-30. PubMed ID: 30961814
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
8. The influence of microenvironment on tumor immunotherapy.
Zhang J; Shi Z; Xu X; Yu Z; Mi J
FEBS J; 2019 Nov; 286(21):4160-4175. PubMed ID: 31365790
[TBL] [Abstract][Full Text] [Related]
9. Interactions between cancer-associated fibroblasts and T-cells: functional crosstalk with targeting and biomarker potential.
Milosevic V; Östman A
Ups J Med Sci; 2024; 129():. PubMed ID: 38863724
[TBL] [Abstract][Full Text] [Related]
10. Targeting galectins in T cell-based immunotherapy within tumor microenvironment.
Jin QY; Li YS; Qiao XH; Yang JW; Guo XL
Life Sci; 2021 Jul; 277():119426. PubMed ID: 33785342
[TBL] [Abstract][Full Text] [Related]
11. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
Balta E; Wabnitz GH; Samstag Y
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260
[TBL] [Abstract][Full Text] [Related]
12. Collagen Fragments Produced in Cancer Mediate T Cell Suppression Through Leukocyte-Associated Immunoglobulin-Like Receptor 1.
Vijver SV; Singh A; Mommers-Elshof ETAM; Meeldijk J; Copeland R; Boon L; Langermann S; Flies D; Meyaard L; Ramos MIP
Front Immunol; 2021; 12():733561. PubMed ID: 34691040
[TBL] [Abstract][Full Text] [Related]
13. Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.
Khalaf K; Hana D; Chou JT; Singh C; Mackiewicz A; Kaczmarek M
Front Immunol; 2021; 12():656364. PubMed ID: 34122412
[TBL] [Abstract][Full Text] [Related]
14. Physical immune escape: Weakened mechanical communication leads to escape of metastatic colorectal carcinoma cells from macrophages.
Yang C; Dong X; Sun B; Cao T; Xie R; Zhang Y; Yang Z; Huang J; Lu Y; Li M; Wang X; Xu Y; Ye F; Fan Q
Proc Natl Acad Sci U S A; 2024 May; 121(22):e2322479121. PubMed ID: 38771871
[TBL] [Abstract][Full Text] [Related]
15. Immune Modulatory Properties of Collagen in Cancer.
Rømer AMA; Thorseth ML; Madsen DH
Front Immunol; 2021; 12():791453. PubMed ID: 34956223
[TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments.
Yuan Z; Li Y; Zhang S; Wang X; Dou H; Yu X; Zhang Z; Yang S; Xiao M
Mol Cancer; 2023 Mar; 22(1):48. PubMed ID: 36906534
[TBL] [Abstract][Full Text] [Related]
17. Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.
Yan L; Tan Y; Chen G; Fan J; Zhang J
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638609
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment: Interactions and therapy.
Najafi M; Goradel NH; Farhood B; Salehi E; Solhjoo S; Toolee H; Kharazinejad E; Mortezaee K
J Cell Physiol; 2019 May; 234(5):5700-5721. PubMed ID: 30378106
[TBL] [Abstract][Full Text] [Related]
19. Proinvasive extracellular matrix remodeling for tumor progression.
Kaushik N; Kim S; Suh Y; Lee SJ
Arch Pharm Res; 2019 Jan; 42(1):40-47. PubMed ID: 30515725
[TBL] [Abstract][Full Text] [Related]
20. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
Gaggero S; Witt K; Carlsten M; Mitra S
Front Immunol; 2020; 11():621225. PubMed ID: 33584718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
